153 related articles for article (PubMed ID: 6248483)
1. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus.
Takada K; Yamamoto K; Osato T
Intervirology; 1980; 13(4):223-31. PubMed ID: 6248483
[TBL] [Abstract][Full Text] [Related]
2. [Studies on transformation of human lymphocytes by Epstein-Barr virus (author's transl)].
Takada K
Hokkaido Igaku Zasshi; 1980 Sep; 55(5):447-70. PubMed ID: 6263773
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the transformation of human lymphocytes by Epstein-Barr virus. I. Sequential occurrence from the virus-determined nuclear antigen synthesis, to blastogenesis, to DNA synthesis.
Takada K; Osato T
Intervirology; 1979; 11(1):30-9. PubMed ID: 218892
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the transformation of human lymphocytes by Epstein-Barr virus III. Induction of early events by P3HR-1 strain without subsequent immortalization.
Takada K; Osato T
Med Microbiol Immunol; 1981; 170(1):19-26. PubMed ID: 6272076
[TBL] [Abstract][Full Text] [Related]
5. Infection of mouse lymphocytes by Epstein-Barr virus. II. Stimulation of cellular DNA synthesis by EBV in the absence of EBNA induction and cell transformation.
Gross TG; Volsky DJ
Virology; 1984 Feb; 133(1):211-5. PubMed ID: 6322431
[TBL] [Abstract][Full Text] [Related]
6. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
7. Cell growth effects of Epstein-Barr virus leader protein.
Allan GJ; Inman GJ; Parker BD; Rowe DT; Farrell PJ
J Gen Virol; 1992 Jun; 73 ( Pt 6)():1547-51. PubMed ID: 1318948
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
Sundar SK; Levine PH; Ablashi DV; Menezes J
Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
[TBL] [Abstract][Full Text] [Related]
10. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus interactions with human lymphocyte subpopulations: virus adsorption, kinetics of expression of Epstein-Barr virus-associated nuclear antigen, and lymphocyte transformation.
Menezes J; Jondal M; Leibold W; Dorval G
Infect Immun; 1976 Feb; 13(2):303-10. PubMed ID: 177360
[TBL] [Abstract][Full Text] [Related]
13. Lymphoblastoid transformation and kinetics of appearance of viral nuclear antigen (EBNA) in cord-blood lymphocytes infected by Epstein-Barr Virus (EBV).
Yata J; Desgranges C; Nakagawa T; Favre MC; De-The G
Int J Cancer; 1975 Mar; 15(3):377-84. PubMed ID: 49325
[TBL] [Abstract][Full Text] [Related]
14. Blastogenic response and EBNA induction in human lymphocytes by Epstein-Barr virus only requires B cells but not macrophages.
Gergely P; Ernberg I
Cancer Lett; 1977 Mar; 2(4-5):217-20. PubMed ID: 45722
[TBL] [Abstract][Full Text] [Related]
15. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV.
Klein G; Sugden B; Leibold W; Menezes J
Intervirology; 1974; 3(4):232-44. PubMed ID: 4376804
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.
Rickinson AB; Finerty S; Epstein MA
Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus infection of rat lymphocytes expressing human CD21 results in restricted latent viral gene expression and not in immunoblastic transformation.
Yang L; Ikeda H; Lai Y; Yoshiki T; Takada K
J Med Virol; 2003 May; 70(1):126-30. PubMed ID: 12629653
[TBL] [Abstract][Full Text] [Related]
18. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
19. In-vitro infection of chronic lymphocytic leukemia cells by Epstein-Barr virus (EBV).
Tatsumi E; Harada S; Bechtold T; Lipscomb H; Davis J; Kuszynski C; Volsky DJ; Han T; Armitage J; Purtilo DT
Leuk Res; 1986; 10(2):167-77. PubMed ID: 3512923
[TBL] [Abstract][Full Text] [Related]
20. Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells.
Rickinson AB; Young LS; Rowe M
J Virol; 1987 May; 61(5):1310-7. PubMed ID: 3033261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
